TLDR: Not yet published, Non-Randomized with control group. 636 Symptomatic Outpatients in Brazil, 412 treated with AZM+HCQ, 224 control group. 1.9% needed hospitalization with HCQ+AZM group. 5.4% needed hospitalization with control group. Trial registry NCT04348474.